Formulation and specifications: Injection: 80mg (2ml)/bottle, 240mg (6ml)/bottleIndications: Indicated for the treatment of unresectable or metastatic melanoma that has failed previous systemic systemic therapy.Key points for rational drug use:1. The…
Formulation and specification: Injection: 100mg (4ml)/bottleIndications: Indicated for the treatment of unresectable or metastatic cutaneous melanoma.Key points for rational drug use:1. The recommended dosing regimen for patients with unresectable or…
Formulation and specifications: Tablets: 0.5mg, 2mgIndications:1. Trametinib in combination with dabrafenib is indicated for the treatment of patients with unresectable or metastatic melanoma positive for BRAF V600 mutation.2. Trametinib in…
Formulation and specifications: Capsules: 50mg, 75mgIndications:1. Darafenib in combination with trametinib is indicated for the treatment of patients with unresectable or metastatic melanoma positive for the BRAF V600 mutation.2. Dabrafenib…
Formulation and Specifications: Tablets: 240 mgIndications: Unresectable or metastatic melanoma positive for BRAF V600 mutation as determined by an assay approved by the State Drug Administration.Key points for rational drug…
Formulation and specifications: (1) Tablets: 100 mg, 400 mg; (2) Capsules: 50 mg, 100 mgIndications: For patients with unresectable and/or metastatic KIT mutations in malignant melanoma.Key points for rational drug…